logo
Sign In
Farxiga vs. GlyxambiBerinert vs. CinryzeEmgality vs. QuliptaFarxiga vs. InvokanaFirazyr vs. SajazirGlyxambi vs. InvokanaInvokamet vs. SynjardyOpzelura vs. DupixentOrencia vs. RinvoqQulipta vs. VyeptiStelara vs. TremfyaSynjardy vs. VictozaTaltz vs. BimzelxVyepti vs. Nurtec ODTView all Comparisons
ADHD drugsAnxiety drugsAsthma drugsAtopic dermatitis drugsDepression drugsHeart failure drugsHypertension drugsLymphoma drugsOsteoarthritis drugsRheumatoid arthritis drugsRosacea drugsSchizophrenia drugsType 2 Diabetes drugsView all Indications
Bayer drugsAbbVie drugsAstraZeneca drugsEli Lilly and Company drugsGenetech drugsGlaxoSmithKline (GSK) drugsNovartis drugsPfizer drugsTakeda Pharmaceuticals drugsTeva Pharmaceuticals drugsAmgen drugsView all Manufacturers
Beta-Adrenergic BlockerAngiotensin Converting Enzyme InhibitorAngiotensin 2 Receptor BlockerCalcium Channel BlockerDiureticsHMG-CoA Reductase InhibitorProton Pump InhibitorSelective Serotonin Reuptake InhibitorNorepinephrine Reuptake InhibitorBenzodiazepinesOpioid AgonistsNonsteroidal Anti-inflammatory DrugsAntiepileptic AgentsAntipsychoticsAntihistaminesView all Classes
Wegovy®Ozempic®Mounjaro®Zepbound®Jardiance®Farxiga®Dupixent®Trulicity®Lyrica®Lipitor®Effexor®Concerta®Depakote®Trintellix®Rexulti®Rinvoq®Verzenio®Taltz®
For ProvidersRequest DemoJoin Research Panel
For BusinessHCP ChannelCommercial O/SEngageMarketplaceOneHubInsight
Tools & MorePrescribing InfoCoverageSavingsPatient ResourcesA-Z IndicationsCompare Drugs
CompanyAboutInsightsCareersContactSecurity
Legit Script Certified
Get the latest insights in your inbox
Follow us
Legit Script Certified
  • Terms and Conditions
  • Privacy Policy
  • © 2025 PrescriberPoint. All Rights Reserved.

    • Anti-epileptic Agent class drugs

    FiltersReset Filters
    30 results

    • dilantin

      (Extended Phenytoin Sodium)
      Parke-Davis Div of Pfizer Inc
      Usage: DILANTIN is indicated for treating tonic-clonic (grand mal) and psychomotor (temporal lobe) seizures, as well as for preventing and treating seizures that occur during or after neurosurgery.

    • felbatol

      (felbamate)
      Meda Pharmaceuticals Inc.
      Usage: Felbatol® is indicated for patients with severe epilepsy who do not respond to other treatments. It may be used as monotherapy or adjunctive therapy for partial seizures in adults, and as adjunctive therapy for partial and generalized seizures in children with Lennox-Gastaut syndrome, with associated risks acknowledged.

    • lamotrigine

      (lamotrigine extended-release)
      Yiling Pharmaceutical, Inc.
      Usage: Lamotrigine Extended-Release Tablets are indicated for adjunctive therapy in patients aged 13 and older with primary generalized tonic-clonic seizures and partial-onset seizures. They can also be used for conversion to monotherapy in individuals with partial-onset seizures on a single antiepileptic drug. Safety is not established in patients under 13.

    • lamotrigine

      (lamotrigine extended-release)
      Camber Pharmaceuticals Inc
      Usage: Lamotrigine Extended-Release Tablets are indicated as adjunctive therapy for primary generalized tonic-clonic seizures and partial-onset seizures in patients aged 13 and older. It is also indicated for conversion to monotherapy for partial-onset seizures in the same age group. Safety in patients under 13 has not been established.

    • lamotrigine

      (Lamotrigine)
      Aurobindo Pharma Limited
      Usage: Lamotrigine tablets for oral suspension are indicated as adjunctive therapy for partial-onset, primary generalized tonic-clonic, and Lennox-Gastaut seizures in patients aged 2 and older. They are also used for maintaining bipolar I disorder, delaying mood episode occurrences, but not for treating acute episodes.

    • lamotrigine

      (Lamotrigine)
      Taro Pharmaceuticals U.S.A., Inc.
      Usage: Lamotrigine is indicated as adjunctive therapy for partial-onset, primary generalized tonic-clonic, and Lennox-Gastaut syndrome seizures in patients aged 2 and older, and for conversion to monotherapy in adults with partial-onset seizures. It is also used for the maintenance treatment of bipolar I disorder to delay mood episodes.

    • lamotrigine

      (Lamotrigine)
      Northstar Rx LLC.
      Usage: Lamotrigine is indicated as adjunctive therapy for partial-onset seizures, primary generalized tonic-clonic seizures, and Lennox-Gastaut syndrome seizures in patients aged 2 and older. It is also used for the maintenance treatment of bipolar I disorder to delay mood episodes, but not for acute episodes.

    • lamotrigine

      (Lamotrigine)
      Aurobindo Pharma Limited
      Usage: Lamotrigine tablets are indicated for adjunctive therapy in epilepsy (partial-onset seizures, primary generalized tonic-clonic seizures, and generalized seizures of Lennox-Gastaut syndrome) in patients aged 2 and older. Additionally, they are used for the maintenance treatment of bipolar I disorder to delay mood episodes.

    • lamotrigine

      (LAMOTRIGINE)
      Amneal Pharmaceuticals of New York LLC
      Usage: Lamotrigine orally disintegrating tablets are indicated for adjunctive therapy in epilepsy, treating partial-onset seizures, primary generalized tonic-clonic seizures, and generalized seizures of Lennox-Gastaut syndrome. They are also used for maintenance treatment of bipolar I disorder to delay mood episode recurrence. Not recommended for acute mood episode treatment.

    • lamotrigine

      (Lamotrigine)
      Ajanta Pharma USA Inc.
      Usage: Lamotrigine orally disintegrating tablets are indicated as adjunctive therapy for epilepsy (partial-onset, primary generalized tonic-clonic, and Lennox-Gastaut syndrome seizures) in patients aged 2 and older. They are also used for maintenance treatment of bipolar I disorder to delay mood episodes but not for acute episodes.